Rheumatoid Arthritis and Mental Health: An In-Depth Review
DOI:
https://doi.org/10.12775/QS.2025.48.67287Keywords
Rheumatoid Arthritis, Depression, inflammation, IL-6 inhibitor, JAK inhibitors, TNF inhibitorsAbstract
Background/Objective: Rheumatoid arthritis (RA) co-occurs with depression and anxiety, driven by shared inflammatory pathways, that impair quality of life and treatment response. This review synthesizes evidence on biological mechanisms, biomarkers, and therapeutic strategies targeting RA-related depression.
Methods: Narrative synthesis of epidemiological, biomarker, pharmacological and lifestyle studies linking RA inflammation to mental health.
Results: Pro-inflammatory cytokines (IL-6, TNF-α) mediate the RA-depression nexus, while elevated IL-6, TNF-α, and CRP levels can be used for predicting depression risk. IL-6 inhibitors, TNF inhibitors and JAK inhibitors demonstrate significant improvement in mental state of the patients. SSRIs/SNRIs provide help in maintaining high-minded mood and pain relief, while Mediterranean diet adherence can halve depression odds. Emerging preclinical data support neuroimmune modulators like aucubin targeting CXCL10/BTN3A2.
Conclusion: Integrated care combining cytokine-targeted therapies, antidepressants, psychological interventions, and anti-inflammatory lifestyle measures optimizes outcomes for RA patients with depression, emphasizing early screening and holistic management.
References
1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722-727. doi:10.1136/ard.62.8.722
2. Puszczewicz M Rheumatology, Issue II Wielka Interna Reumatologia Wydanie II, 2016 Warszawa, Medical Tribune Polska, Polish
3. Mental Health, WHO; https://www.who.int/health-topics/mental-health#tab=tab_1
4. Scott IC, Machin A, Mallen CD, Hider SL. The extra-articular impacts of rheumatoid arthritis: moving towards holistic care. BMC Rheumatol. 2018;2:32. Published 2018 Oct 30. doi:10.1186/s41927-018-0039-2
5. “Living with Rheumatoid arthritis, NHS,” 28 August 2019. [Online]. Available: https://www.nhs.uk/conditions/rheumatoid-arthritis/living-with/.
6. Vestergaard SB, Esbensen BA, Klausen JM, Glintborg B, Lau L, Yilmaz Jantzen C, et al. Prevalence of anxiety and depression and the association with self-management behaviour in >12 000 patients with inflammatory rheumatic disease: a cross-sectional nationwide study. RMD Open. 2024;10:e003412. https://doi.org/10.1136/rmdopen-2023-003412
7. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(12):2136-2148. doi:10.1093/rheumatology/ket169
8. Lin MC, Guo HR, Lu MC, Livneh H, Lai NS, Tsai TY. Increased risk of depression in patients with rheumatoid arthritis: a seven-year populationbased cohort study. Clinics. 2015;70(2):91-96. DOI: 10.6061/clinics/2015(02)04
9. Satyanand Sahu1, Sandipan Chatterjee, Kusu Susan Cyriac. Bidirectional Association between Arthritis and Mental Health- A Review, International Journal of Pharmaceutical Research and Applications Volume 9, Issue 2 Mar-Apr 2024, DOI: 10.35629/7781-090211921202
10. Mahdi Naeim, Depression and anxiety in patients with rheumatoid arthritis, Romanian Journal of Rheumatology – Volume 32, No. 3, 2023, DOI: 10.37897/RJR.2023.3.5
11. Lwin MN, Serhal L, Holroyd C, Edwards CJ. Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatol Ther. 2020;7(3):457-471. doi:10.1007/s40744-020-00217-4
12. Zhang, C. (2021). Flare up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment (Review). Biomedical Reports, 14, 16. https://doi.org/10.3892/br.2020.1392
13. Vallerand IA, Patten SB, Barnabe C. Depression and the risk of rheumatoid arthritis. Curr Opin Rheumatol. 2019;31(3):279-284. doi:10.1097/BOR.0000000000000597
14. Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. 2016;12(9):532-542. doi:10.1038/nrrheum.2016.112
15. Ernest H S Choy, Leonard H Calabrese, Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis, Rheumatology, Volume 57, Issue 11, November 2018, Pages 1885–1895, https://doi.org/10.1093/rheumatology/kex391
16. Ingegnoli Francesca , Buoli Massimiliano , Antonucci Flavia , Coletto Lavinia Agra , Esposito Cecilia Maria , Caporali Roberto. The Link Between Autonomic Nervous System and Rheumatoid Arthritis: From Bench to Bedside. Frontiers in Medicine. 2020; Volume 7 – 2020. DOI=10.3389/fmed.2020.589079
17. Cox N, Hawarden A, Bajpai R, et al. The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol. Rheumatol Int. 2024;44(3):435-440. doi:10.1007/s00296-023-05450-y
18. Maldonado G, Ríos C, Paredes C, Ferro C, Intriago MJ, Aguirre C, et al. Depresión en artritis reumatoide. Rev Colomb Reumatol. 2017;24:84–91. DOI: 10.1016/j.rcreue.2017.07.001
19. Husted, J.A., Tom, B.D., Farewell, V.T. and Gladman, D.D. (2012), Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res, 64: 758-765. https://doi.org/10.1002/acr.21602
20. Liu Nian , Yan Weitian , Su Rong , Zhang Lin , Wang Xingqiang , Li Zhaofu , Qin Dongdong , Peng Jiangyun .Research progress on rheumatoid arthritis-associated depression. Frontiers in Behavioral Neuroscience. 2023; Volume 16 – 2022. DOI=10.3389/fnbeh.2022.992223
21. Depression in adults, NHS website for England, https://www.nhs.uk/mental-health/conditions/depression-in-adults/
22. Hitchon, C.A., Zhang, L., Peschken, C.A., Lix, L.M., Graff, L.A., Fisk, J.D., Patten, S.B., Bolton, J., Sareen, J., El-Gabalawy, R., Marriott, J., Bernstein, C.N. and Marrie, R.A. (2020), Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care Res, 72: 1130-1139. https://doi.org/10.1002/acr.24011
23. Mrđa J, Tadić-Latinović L, Božić Majstorović L, et al. Association of TNF-α and IL-6 Concentrations with Depression in Patients with Rheumatoid Arthritis. Curr Issues Mol Biol. 2025;47(6):419. Published 2025 Jun 5. doi:10.3390/cimb47060419
24. Figueiredo-Braga M, Cornaby C, Cortez A, et al. Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis. J Immunol Res. 2018;2018:5954897. Published 2018 Jul 17. doi:10.1155/2018/5954897
25. Parmar H, Joshi P, Singh R, Parmar S, Sharma R. A Cross-Sectional Study of Depression in Rheumatoid Arthritis Patients at a Tertiary Care Center. J Pharm Bioallied Sci. 2025;17(Suppl 1):S634-S637. doi:10.4103/jpbs.jpbs_1478_24
26. Miwa Y, Ohashi Y, Tomatsu H, Mitamura Y. Efficacy of Plasma Phosphoethanolamine as a Biomarker for Rheumatoid Arthritis-associated Depression [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/efficacy-of-plasma-phosphoethanolamine-as-a-biomarker-for-rheumatoid-arthritis-associated-depression/. Accessed December 7, 2025.
27. Zhou TT, Sun JJ, Tang LD, Yuan Y, Wang JY, Zhang L. Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis. Front Immunol. 2023;14:1007624. Published 2023 Feb 23. doi:10.3389/fimmu.2023.1007624
28. Nagy Z, Szigedi E, Takács S, Császár-Nagy N. The Effectiveness of Psychological Interventions for Rheumatoid Arthritis (RA): A Systematic Review and Meta-Analysis. Life (Basel). 2023;13(3):849. Published 2023 Mar 21. doi:10.3390/life13030849
29. Agnieszka Pigłowska-Juhnke, Aleksandra Rutkowska , Włodzimierz Samborski, Piotr Kalmus, Ewa Mojs, Effectiveness of cognitive-behavioural therapy in patients with rheumatoid arthritis. Research review, Forum Reumatol. 2018, tom 4, nr 1: 15–25
30. Betz, L.T., Jacob, G.A., Knitza, J. et al. Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial. npj Mental Health Res 3, 41 (2024). https://doi.org/10.1038/s44184-024-00085-8
31. Slagter L, Demyttenaere K, Verschueren P, De Cock D. The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis. J Pers Med. 2022;12(11):1905. Published 2022 Nov 15. doi:10.3390/jpm12111905
32. Koulouris A, Dorado K, McDonnell C, Edwards RR, Lazaridou A. A Review of the Efficacy of Yoga and Meditation-Based Interventions for Rheumatoid Arthritis. OBM Integrative and Complementary Medicine 2018; 3(3): 018; doi:10.21926/obm.icm.1803018.
33. Ma L, Yuan J, Yang X, Yan M, Li Y, Niu M. Association between the adherence to Mediterranean diet and depression in rheumatoid arthritis patients: a cross-sectional study from the NHANES database. J Health Popul Nutr. 2024;43(1):103. Published 2024 Jul 5. doi:10.1186/s41043-024-00572-w
34. Açıkalın Göktürk Büşra , Sanlier Nevin. Genetic factors may load the gun, but environmental factors pull the trigger: MedDiet and DII in rheumatoid arthritis. Frontiers in Nutrition. 2025; Volume 12 – 2025. DOI=10.3389/fnut.2025.1629896
35. Manning-Bennett AT, Hopkins AM, Sorich MJ, et al. The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials. Ther Adv Musculoskelet Dis. 2022;14:1759720X221111613. Published 2022 Jul 22. doi:10.1177/1759720X221111613
36. Dr. Kiran Kumar N, A Comparative Evaluation of Antidepressant Medications: SSRIs vs. SNRIs in Treating Major Depressive Disorder International Journal of Life Sciences, Biotechnology and Pharma Research Vol. 10, No. 1, Jan- June 2021 Online ISSN: 2250-3137
37. Serge Perrot, Rationalizing the use of antidepressants in painful rheumatic conditions. Future Rheumatol. (2006) 1(4), 387–391. 10.2217/17460816.1.4.387 © 2006 Future Medicine Ltd ISSN 1746-0816
38. De Luca B, Canozzi A, Mosconi C, et al. Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis. The British Journal of Psychiatry. 2025;227(2):553-566. doi:10.1192/bjp.2025.18
39. Baghdadi LR. Tocilizumab Reduces Depression Risk in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Psychol Res Behav Manag. 2024;17:3419-3441. Published 2024 Oct 4. doi:10.2147/PRBM.S482409v
40. Siuchnińska H, Minarowska A, Wasilewska E. Beyond Joints: Neuropsychiatric Benefits of TNF-α and IL-6 Inhibitors in Rheumatoid Arthritis-Narrative Review. Int J Mol Sci. 2025;26(17):8361. Published 2025 Aug 28. doi:10.3390/ijms26178361
41. Sebba A, Bingham CO, Bykerk VP, et al. Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry. Clin Rheumatol. 2023;42(8):2037-2051. doi:10.1007/s10067-023-06588-7
42. Knight, J.M., Costanzo, E.S., Singh, S. et al. The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill. Transl Psychiatry 11, 58 (2021). https://doi.org/10.1038/s41398-020-01164-y
43. Shamail GMH, Haridoss M, Natarajan M, Joshua V, Bagepally BS. Association Between Janus Kinase Inhibitors Therapy and Mental Health Outcome in Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Rheumatol Ther. 2022;9(2):313-329. doi:10.1007/s40744-021-00409-6
44. Morinobu, A. (2020). JAK inhibitors for the treatment of rheumatoid arthritis. Immunological Medicine, 43(4), 148–155. https://doi.org/10.1080/25785826.2020.1770948
45. Omar Al Tabaa, Sophie Hecquet, Marion Thomas, Sandrine Carvès, Alice Combier, Corinne Miceli-Richard, Anna Molto, Olivier Fogel, Yannick Allanore, Jérôme Avouac. Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 2024; Volume 69, 152572. https://doi.org/10.1016/j.semarthrit.2024.152572.
46. Solitano V, Ahuja D, Lee HH, et al. Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2025;8(9):e2531204. doi:10.1001/jamanetworkopen.2025.31204
47. Roberts WK, Blachère NE, Frank MO, Dousmanis A, Ransohoff RM, Darnell RB. A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. Ann Neurol. 2015;78(4):619-629. doi:10.1002/ana.24494
48. Yang P, Zhang Q, Shen H, Bai X, Liu P, Zhang T. Research progress on the protective effects of aucubin in neurological diseases. Pharm Biol. 2022;60(1):1088-1094. doi:10.1080/13880209.2022.2074057
49. Kim YM, Sim UC, Shin Y, Kim Kwon Y. Aucubin promotes neurite outgrowth in neural stem cells and axonal regeneration in sciatic nerves. Exp Neurobiol. 2014;23(3):238-245. doi:10.5607/en.2014.23.3.238
50. Xue, H.-Y., Gao, G.-Z., Lin, Q.-Y., Jin, L.-J. and Xu, Y.-P. (2012), Protective Effects of Aucubin on H2O2-Induced Apoptosis in PC12 Cells. Phytother. Res., 26: 369-374. https://doi.org/10.1002/ptr.3562
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Wiktoria Toczek, Klaudia Bogdan , Mikołaj Jankowski , Magdalena Olszówka, Urszula Janicka, Natalia Ciepluch, Szymon Stanisław Słomiński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 5
Number of citations: 0
